Cargando…

Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy

BACKGROUND: Genetic testing of relatives of hypertrophic cardiomyopathy (HCM) patients has led to a large group of genotype‐positive, phenotype‐negative (G+/Ph−) subjects. Prediction of progression to overt HCM in these subjects is challenging. While left atrial (LA) strain is reduced in HCM patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Huurman, Roy, Bowen, Daniel J., Mutluer, Ferit O., Loff Barreto, Bernardo, van Slegtenhorst, Marjon A., Verhagen, Judith M. A., Hirsch, Alexander, van den Bosch, Annemien E., Michels, Michelle, Schinkel, Arend F. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544609/
https://www.ncbi.nlm.nih.gov/pubmed/35978457
http://dx.doi.org/10.1111/echo.15434
_version_ 1784804634551910400
author Huurman, Roy
Bowen, Daniel J.
Mutluer, Ferit O.
Loff Barreto, Bernardo
van Slegtenhorst, Marjon A.
Verhagen, Judith M. A.
Hirsch, Alexander
van den Bosch, Annemien E.
Michels, Michelle
Schinkel, Arend F. L.
author_facet Huurman, Roy
Bowen, Daniel J.
Mutluer, Ferit O.
Loff Barreto, Bernardo
van Slegtenhorst, Marjon A.
Verhagen, Judith M. A.
Hirsch, Alexander
van den Bosch, Annemien E.
Michels, Michelle
Schinkel, Arend F. L.
author_sort Huurman, Roy
collection PubMed
description BACKGROUND: Genetic testing of relatives of hypertrophic cardiomyopathy (HCM) patients has led to a large group of genotype‐positive, phenotype‐negative (G+/Ph−) subjects. Prediction of progression to overt HCM in these subjects is challenging. While left atrial (LA) strain is reduced in HCM patients it is currently unknown whether this parameter can be used to predict HCM phenotype progression. METHODS: This study includes 91 G+/Ph− subjects and 115 controls. Standard echocardiographic parameters as well as left ventricular global longitudinal strain (LV GLS) and LA reservoir strain (LASr) were assessed for each patient. Logistic and Cox proportional hazard regression analyses were used to investigate predictors of G+/Ph− status and HCM during follow‐up. RESULTS: Independent predictors of G+ status included pathological Q waves (OR 1.60 [1.15–2.23], p < .01), maximal wall thickness (MWT: OR 1.10 [1.07–1.14], p < .001), mitral inflow E wave (OR 1.06 [1.02–1.10, p = .001), A wave (OR 1.06 [1.03–1.10], p < .001), LV GLS (OR .96 [.94–.98], p < .001), and LASr (OR .99 [.97–.99], p = .03). In univariable Cox regression analysis, male sex (HR 2.78 [1.06–7.29], p = .04), MWT (HR 1.72 [1.14–2.57], p = .009) and posterior wall thickness (HR 1.65 [1.17–2.30], p = .004) predicted HCM during a median follow‐up of 5.9 [3.2–8.6] years, whereas LASr did not (HR .95 [.89–1.02], p = .14). There were no significant predictors of HCM after multivariable adjustment. CONCLUSION: LASr is significantly impaired in G+/Ph− subjects and is an independent predictor of G+/Ph− status, but did not predict HCM development during follow‐up.
format Online
Article
Text
id pubmed-9544609
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95446092022-10-14 Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy Huurman, Roy Bowen, Daniel J. Mutluer, Ferit O. Loff Barreto, Bernardo van Slegtenhorst, Marjon A. Verhagen, Judith M. A. Hirsch, Alexander van den Bosch, Annemien E. Michels, Michelle Schinkel, Arend F. L. Echocardiography Original Articles BACKGROUND: Genetic testing of relatives of hypertrophic cardiomyopathy (HCM) patients has led to a large group of genotype‐positive, phenotype‐negative (G+/Ph−) subjects. Prediction of progression to overt HCM in these subjects is challenging. While left atrial (LA) strain is reduced in HCM patients it is currently unknown whether this parameter can be used to predict HCM phenotype progression. METHODS: This study includes 91 G+/Ph− subjects and 115 controls. Standard echocardiographic parameters as well as left ventricular global longitudinal strain (LV GLS) and LA reservoir strain (LASr) were assessed for each patient. Logistic and Cox proportional hazard regression analyses were used to investigate predictors of G+/Ph− status and HCM during follow‐up. RESULTS: Independent predictors of G+ status included pathological Q waves (OR 1.60 [1.15–2.23], p < .01), maximal wall thickness (MWT: OR 1.10 [1.07–1.14], p < .001), mitral inflow E wave (OR 1.06 [1.02–1.10, p = .001), A wave (OR 1.06 [1.03–1.10], p < .001), LV GLS (OR .96 [.94–.98], p < .001), and LASr (OR .99 [.97–.99], p = .03). In univariable Cox regression analysis, male sex (HR 2.78 [1.06–7.29], p = .04), MWT (HR 1.72 [1.14–2.57], p = .009) and posterior wall thickness (HR 1.65 [1.17–2.30], p = .004) predicted HCM during a median follow‐up of 5.9 [3.2–8.6] years, whereas LASr did not (HR .95 [.89–1.02], p = .14). There were no significant predictors of HCM after multivariable adjustment. CONCLUSION: LASr is significantly impaired in G+/Ph− subjects and is an independent predictor of G+/Ph− status, but did not predict HCM development during follow‐up. John Wiley and Sons Inc. 2022-08-17 2022-09 /pmc/articles/PMC9544609/ /pubmed/35978457 http://dx.doi.org/10.1111/echo.15434 Text en © 2022 The Authors. Echocardiography published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Huurman, Roy
Bowen, Daniel J.
Mutluer, Ferit O.
Loff Barreto, Bernardo
van Slegtenhorst, Marjon A.
Verhagen, Judith M. A.
Hirsch, Alexander
van den Bosch, Annemien E.
Michels, Michelle
Schinkel, Arend F. L.
Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy
title Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy
title_full Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy
title_fullStr Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy
title_full_unstemmed Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy
title_short Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy
title_sort prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544609/
https://www.ncbi.nlm.nih.gov/pubmed/35978457
http://dx.doi.org/10.1111/echo.15434
work_keys_str_mv AT huurmanroy prognosticsignificanceofleftatrialstraininsarcomeregenevariantcarrierswithouthypertrophiccardiomyopathy
AT bowendanielj prognosticsignificanceofleftatrialstraininsarcomeregenevariantcarrierswithouthypertrophiccardiomyopathy
AT mutluerferito prognosticsignificanceofleftatrialstraininsarcomeregenevariantcarrierswithouthypertrophiccardiomyopathy
AT loffbarretobernardo prognosticsignificanceofleftatrialstraininsarcomeregenevariantcarrierswithouthypertrophiccardiomyopathy
AT vanslegtenhorstmarjona prognosticsignificanceofleftatrialstraininsarcomeregenevariantcarrierswithouthypertrophiccardiomyopathy
AT verhagenjudithma prognosticsignificanceofleftatrialstraininsarcomeregenevariantcarrierswithouthypertrophiccardiomyopathy
AT hirschalexander prognosticsignificanceofleftatrialstraininsarcomeregenevariantcarrierswithouthypertrophiccardiomyopathy
AT vandenboschannemiene prognosticsignificanceofleftatrialstraininsarcomeregenevariantcarrierswithouthypertrophiccardiomyopathy
AT michelsmichelle prognosticsignificanceofleftatrialstraininsarcomeregenevariantcarrierswithouthypertrophiccardiomyopathy
AT schinkelarendfl prognosticsignificanceofleftatrialstraininsarcomeregenevariantcarrierswithouthypertrophiccardiomyopathy